{"id":994675,"date":"2026-08-13T07:05:01","date_gmt":"2026-08-13T11:05:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/"},"modified":"2026-08-13T07:05:01","modified_gmt":"2026-08-13T11:05:01","slug":"nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/","title":{"rendered":"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight"},"content":{"rendered":"<div class=\"mw_release\">\n<p>ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) &#8212; Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug 26<sup>th<\/sup> as part of the CEO spotlight event.<\/p>\n<p>The Georgia Life Sciences Summit brings together leaders from across biotechnology, medical technology, research, manufacturing, and investment to showcase Georgia\u2019s emergence as a national leader in life sciences innovation.<\/p>\n<p>The Summit takes place on Aug 25-26 at the Sandy Springs Performing Arts Centre located at 1 Galambos Way, Sandy Springs, Georgia.<\/p>\n<p>\n        <strong>About AVERSA\u2122 Abuse-Deterrent Transdermal Technology<\/strong>\n      <\/p>\n<p>Nutriband&#8217;s AVERSA\u2122 abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The AVERSA\u2122 abuse-deterrent technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to those patients who really need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia.<\/p>\n<p>\n        <strong>About Nutriband Inc.<\/strong>\n      <\/p>\n<p>We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA\u2122 abuse-deterrent technology. AVERSA\u2122 technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.<\/p>\n<p>The Company&#8217;s website is <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=utMTxG-KyrpmL4G7PvXTmo7q-4cZsd1KX2GHFxy4EjH4HvJzxZYpguFZLQDVe-wAoxWZdEmqCAGQlRYP7-zsBpkidg9jeNdwgo7nv44KlAk=\" rel=\"nofollow\" target=\"_blank\">www.nutriband.com<\/a>. Any material contained in or derived from the Company&#8217;s websites or any other website is not part of this press release.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">Certain statements contained in this press release, including, without limitation, statements containing the words \u2018&#8217;believes,&#8221; &#8220;anticipates,&#8221; &#8220;expects&#8221; and words of similar import, constitute &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company&#8217;s actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company&#8217;s ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company&#8217;s business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in the Company&#8217;s Form S-1, Forms 10-K\u2019s and Forms 10-Q\u2019s, and the Company&#8217;s other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.<\/p>\n<p>Contact Information:<\/p>\n<p>Nutriband Inc.<br \/>Phone: 407-377-6695<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PrM_E5FeL9p6GTMd6fhfK3zTqozHO_q4Zg1K0NOmySJsjVnkOLH-Osnnr9K8IVhtVY5_wocHaHQ0GQ7w9bE6pQSL5l7xRmrhMIY-eDzL3B4=\" rel=\"nofollow\" target=\"_blank\">info@nutriband.com<\/a><\/p>\n<p>SOURCE: Nutriband Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDkxMTllZjUtOTI2Zi00MTU3LTliYzUtNWExZGFlZTY2YTJmLTEzMDgzNDktMjAyNi0wOC0xMy1lbg==\/tiny\/Nutriband-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) &#8212; Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug 26th as part of the CEO spotlight event. The Georgia Life Sciences Summit brings together leaders from across biotechnology, medical technology, research, manufacturing, and investment to showcase Georgia\u2019s emergence as a national leader in life sciences innovation. The Summit takes place on Aug 25-26 at the Sandy Springs Performing Arts Centre located at 1 Galambos Way, Sandy Springs, Georgia. About AVERSA\u2122 Abuse-Deterrent Transdermal Technology Nutriband&#8217;s AVERSA\u2122 abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-994675","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) &#8212; Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug 26th as part of the CEO spotlight event. The Georgia Life Sciences Summit brings together leaders from across biotechnology, medical technology, research, manufacturing, and investment to showcase Georgia\u2019s emergence as a national leader in life sciences innovation. The Summit takes place on Aug 25-26 at the Sandy Springs Performing Arts Centre located at 1 Galambos Way, Sandy Springs, Georgia. About AVERSA\u2122 Abuse-Deterrent Transdermal Technology Nutriband&#8217;s AVERSA\u2122 abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. &hellip; Continue reading &quot;Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-13T11:05:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight\",\"datePublished\":\"2026-08-13T11:05:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/\"},\"wordCount\":586,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/\",\"name\":\"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=\",\"datePublished\":\"2026-08-13T11:05:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/","og_locale":"en_US","og_type":"article","og_title":"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight - Market Newsdesk","og_description":"ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) &#8212; Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug 26th as part of the CEO spotlight event. The Georgia Life Sciences Summit brings together leaders from across biotechnology, medical technology, research, manufacturing, and investment to showcase Georgia\u2019s emergence as a national leader in life sciences innovation. The Summit takes place on Aug 25-26 at the Sandy Springs Performing Arts Centre located at 1 Galambos Way, Sandy Springs, Georgia. About AVERSA\u2122 Abuse-Deterrent Transdermal Technology Nutriband&#8217;s AVERSA\u2122 abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. &hellip; Continue reading \"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-13T11:05:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight","datePublished":"2026-08-13T11:05:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/"},"wordCount":586,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/","name":"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=","datePublished":"2026-08-13T11:05:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwOTE4MiM3Nzc0MTE5IzIyOTY3OTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summit-as-part-of-the-ceo-spotlight\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/994675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=994675"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/994675\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=994675"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=994675"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=994675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}